Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›ZELA Stock (ZELA)
Track ZELA stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ZELA
ZELA
—
No price data available for 1Y.
Market Cap
—
P/E Ratio
—
1Y Return
—
EPS (TTM)
—
Read the latest TheStreet Pro articles mentioning ZELA, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning ZELA yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning